Search
Phathom Pharmaceuticals Inc
PHATAdd to Watchlist
10.880USD
-0.120-1.09%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
867.74MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Phathom Pharmaceuticals Inc is 8.55, ranking 31 out of 157 in the Pharmaceuticals industry. The average price target is 20.00, with a high of 29.00 and a low of 12.00.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
23.700
Target Price
+117.83%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Phathom Pharmaceuticals Inc
PHAT
11
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Phathom Pharmaceuticals Inc's expected revenue for the next quarter?
Phathom Pharmaceuticals Inc's expected revenue is 73.93M.
What is Phathom Pharmaceuticals Inc's price target?
Analysts forecast that Phathom Pharmaceuticals Inc's price target is USD 20.00, with the highest forecast at USD 29.00 and the lowest forecast at USD 12.00.
How have Phathom Pharmaceuticals IncPHAT's recent earnings per share performed?
The market expectation was USD -0.37, while Phathom Pharmaceuticals IncPHAT's earnings per share (EPS) for the previous quarter was USD -0.29. EPS for the next quarter is expected at USD -0.24.
What is the analyst rating for Phathom Pharmaceuticals Inc?
Based on the ratings of Phathom Pharmaceuticals Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
